Isis Pharmaceuticals (ISIS) in Focus: Stock Soars 10.7% – Tale of the Tape

January 6, 2015 Technicals 0

Zacks

Isis Pharmaceuticals, Inc. (ISIS) was a big mover last session, as the company saw its shares soar nearly 11% on the day. The move came on the back of a licensing deal with Johnson & Johnson worth up to $835 million. This led to far more shares changing hands than in a normal session resulting in solid volume. This reverses the recent trend of the company, as the stock is now trading above the volatile price range of $52.76 to $65.09 in the past one-month time frame.

The company has seen five positive revisions in the past 60 days, while its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for this industry stock. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Isis Pharmaceuticals currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

A better-ranked stock in the same industry is Affymetrix Inc. (AFFX), carrying a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

Be the first to comment

Leave a Reply